[1]
“ADVANCEMENTS IN TARGETED CANCER THERAPIES: FROM MONOCLONAL ANTIBODIES TO IMMUNOTHERAPY”, IJFANS, vol. 11, no. 12, pp. 17887–17896, Jan. 2022, Accessed: Jul. 17, 2026. [Online]. Available: https://www.ijfans.org/index.php/Journal/article/view/14322